1,3-Dimethyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid

Catalog No. :
ACQLDB468
CAS No. :
954264-63-2
Molecular Formula :
C14H12N4O2
Molecular Weight :
268.28

IUPAC Name:1,3-dimethyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid

1,3-Dimethyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$240.00Login to see priceInquiryInquiry
5g97%$722.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Dimethyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
IUPAC Name1,3-dimethyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
Molecular FormulaC14H12N4O2
Molecular Weight268.28
SMILESO=C(C1=C2C(N(C)N=C2C)=NC(C3=CC=CN=C3)=C1)O
InChI KeyPWJKXCJMWFWZHK-UHFFFAOYSA-N
Synonym1,3-Dimethyl-6-(3-pyridyl)pyrazolo[3,4-b]pyridine-4-carboxylic acid;1,3-dimethyl-6-pyridin-3-ylpyrazolo[3,4-b]pyridine-4-carboxylic acid;1H-Pyrazolo[3,4-b]pyridine-4-carboxylic acid, 1,3-dimethyl-6-(3-pyridinyl)-
CAS No.954264-63-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQLDB468 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQLDB468 route product structure diagram
    ACQLDB468954264-63-2
Inquiry

2. ACQLDB468 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7 In Stock
  4. Then
  5. ACQLDB468 route product structure diagram
    ACQLDB468954264-63-2
Inquiry

Comments (0)